Synthesis of C-14 radiolabeled glucagon receptor antagonist and its use in a human mass balance study.

J Labelled Comp Radiopharm

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Published: February 2017

The synthesis of the radiolabeled glucagon receptor antagonist 1-[ C] was accomplished based on decarboxylative iodination of acid 2 followed by "reattachment" of C carboxylic function. The method allowed a significant reduction in the number of steps in preparation of the radiolabeled compound. Iodide 4, obtained by the halodecarboxylation, was converted to cyanide 5-[ C], which was hydrolyzed to provide the radiolabeled acid 2-[ C]. Coupling with β-alanine fragment and hydrolysis of ester 6-[ C] completed the synthesis of the target molecule 1-[ C]. The resulting compound was utilized in a mass balance and metabolism study where hepatic oxidation followed by a trace amount of sulfate conjugation and elimination was the main clearance pathway for 1 in humans.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jlcr.3477DOI Listing

Publication Analysis

Top Keywords

radiolabeled glucagon
8
glucagon receptor
8
receptor antagonist
8
mass balance
8
synthesis c-14
4
radiolabeled
4
c-14 radiolabeled
4
antagonist human
4
human mass
4
balance study
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!